FTH
Faeth Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.99
+1.73%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-131.2%
Return on equity
-118.1%
Return on assets
-134.0%
Return on invested capital
0.00x
Asset turnover
-$43.3M
Cash from operations
$6.76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026